Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
44 participants
INTERVENTIONAL
2023-06-29
2027-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Amputations of one, several or all toes, called complete transmetatarsal amputations, may take several months to heal. Amputations require directed healing and, above all, monitoring of the underlying tissues of the amputated area by daily detersions and wiping performed by a nurse at home. The mechanical detersion of the wound necessary for the healing process and cell migration, as well as optimal deep meshing, facilitate the evolution of the healing process.
These treatments often cause pain, despite oral analgesics and local anaesthetics prior to the treatment.
For several years, studies have shown the benefits of hypnosis in modifying the perception of pain, particularly during treatment.
Studies have also shown that self-hypnosis allows a reduction in the intensity of pain.
The clinical experience of the vascular surgery department of the University Hospital of Rennes suggests that patients who use self-hypnosis during the daily dressing of their amputation experience the moment more serenely, increasing their comfort and decreasing their pain and anxiety.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Wound Necrosis in Lower Extremity Surgery
NCT03351387
Anesthesia Technique and Lower Limb Revascularization Patency
NCT04730310
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
NCT01293214
Interventional Radiology in Bony Lesions
NCT05738941
Wide-Awake Local Anesthesia For Flexor Tendon Repair
NCT03752957
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
self-hypnosis and care
self-hypnosis and dressing
self-hypnosis during dressing
care
dressing
dressing without self-hypnosis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
self-hypnosis and dressing
self-hypnosis during dressing
dressing
dressing without self-hypnosis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Naïve to amputation procedures;
* Amputated, within 24 hours prior to inclusion, one, more or all toes
* Pain level on the Numerical Scale ≥ 3 during the first dressing;
* Affiliated to a social security scheme;
* Having signed a free, informed and written consent.
Exclusion Criteria
* Cultural limitations reducing abstraction skills;
* Previous practice of hypnosis;
* Contraindications to hypnosis: Bipolar disorder or decompensated schizophrenia;
* Chronic non-vascular pain;
* Already in care for painful chronic wounds (ulcer wounds, bedsores...)
* On morphine before surgery;
* Analgesia by perineural catheter;
* Protected person (adult subject to legal protection (safeguard of justice, curatorship, guardianship), person deprived of liberty, pregnant woman (declarative), nursing woman and minor).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rennes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Claudie BOUFFORT
Role: PRINCIPAL_INVESTIGATOR
CHU Rennes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Rennes
Rennes, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Claudie BOUFFORT
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-A00638-35
Identifier Type: OTHER
Identifier Source: secondary_id
35RC20_8896_MODOUPAAH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.